Parallax Volatility Advisers
AZN icon

Parallax Volatility Advisers’s AstraZeneca AZN Stock Holding History

Parallax Volatility Advisers’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,000
Closed -$2.76M – 1471
2025
Q4 		$2.76M Hold
15,000
– – 0.01% 855
2025
Q3 		$2.3M Buy
+15,000
New +$2.27M ﹤0.01% 883
2025
Q2 		– Sell
-43,100
Closed -$6.34M – 1557
2025
Q1 		$6.34M Sell
43,100
-37,500
-47% -$5.43M 0.02% 557
2024
Q4 		$10.6M Buy
80,600
+72,050
+843% +$10.1M 0.02% 551
2024
Q3 		$1.33M Buy
8,550
+5,100
+148% +$823K ﹤0.01% 1272
2024
Q2 		$538K Sell
3,450
-111,150
-97% -$16.7M ﹤0.01% 1423
2024
Q1 		$15.5M Buy
114,600
+88,550
+340% +$11.7M 0.03% 378
2023
Q4 		$3.51M Sell
26,050
-3,900
-13% -$507K 0.01% 957
2023
Q3 		$4.06M Sell
29,950
-134,350
-82% -$18.3M 0.01% 845
2023
Q2 		$23.5M Buy
164,300
+157,750
+2,408% +$23.2M 0.05% 306
2023
Q1 		$909K Sell
6,550
-28,700
-81% -$3.86M ﹤0.01% 1540
2022
Q4 		$4.78M Sell
35,250
-38,800
-52% -$4.87M 0.01% 1045
2022
Q3 		$8.12M Buy
74,050
+32,250
+77% +$4.09M 0.01% 830
2022
Q2 		$5.52M Buy
41,800
+27,750
+198% +$3.64M 0.01% 937
2022
Q1 		$1.86M Buy
+14,050
New +$1.68M ﹤0.01% 1390
2020
Q4 		– Sell
-45,800
Closed -$5.02M – 2397
2020
Q3 		$5.02M Buy
45,800
+40,600
+781% +$4.52M ﹤0.01% 1312
2020
Q2 		$549K Buy
+5,200
New +$537K ﹤0.01% 1945
2019
Q1 		– Sell
-100
Closed -$8K – 2766
2018
Q4 		$8K Sell
100
-400
-80% -$31.2K ﹤0.01% 2529
2018
Q3 		$40K Buy
+500
New +$37.8K ﹤0.01% 1941
2018
Q2 		– Sell
-200
Closed -$14K – 2107
2018
Q1 		$14K Buy
+200
New +$13.9K ﹤0.01% 1767
2017
Q3 		– Sell
-164,550
Closed -$11.2M – 2083
2017
Q2 		$11.2M Buy
164,550
+136,750
+492% +$8.93M 0.02% 374
2017
Q1 		$1.73M Buy
+27,800
New +$1.62M ﹤0.01% 922

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Parallax Volatility Advisers's AZN Position: Q1 2026 in Review

Parallax Volatility Advisers sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 63,249 shares — an estimated $11.6M sold.

Parallax Volatility Advisers first reported a position in AZN in Q4 2015 and held it in 23 quarters. The position peaked at $11.6M in Q4 2025. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Parallax Volatility Advisers reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Parallax Volatility Advisers sold 63,249 AstraZeneca shares in Q1 2026, an estimated $11.6M.
  • Parallax Volatility Advisers first reported a position in AstraZeneca in Q4 2015 and held it in 23 quarters.
  • Parallax Volatility Advisers's AstraZeneca position peaked at $11.6M in Q4 2025.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.